| 标题： | 心源性卒中治疗中国专家共识（2022） |
| title： | Chinese Expert Consensus on the Treatment of Cardioembolic Stroke (2022 edition) |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 本共识面向神经内科医师以及相关科室及专业人员。 |
| Guide users： | This consensus will be helpful for neurologists and related departments or professionals. |
| 证据分级方法： | 定期收集国内外指南、共识、临床研究等方面相关文献，采用GRADE方法对收集的证据进行评分。 |
| Evidence grading method： | Classification method-GRADE |
| 制定单位： | 中华医学会老年医学分会老年神经病学组，北京神经科学学会血管神经病学专业委员会，心源性卒中治疗中国专家共识组 |
| Formulating unit： | Group of Geriatric Neurology, Chinese Society of Geriatrics, Chinese Medical Association；Vascular Neurology Committee, Beijing Neuroscience Society；Chinese Expert consensus group on the treatment of cardiogenic stroke |
| 注册时间： | 2022-10-15 |
| Registration time： | |
| 注册编号： | PREPARE-2022CN650 |
| Registration number： | |
| 指南制订的目的： | 心源性栓塞性卒中（cardioembolic stroke，CES），简称心源性卒中，是指来自心脏和主动脉弓的栓子通过循环导致脑动脉栓塞引起相应脑功能障碍的临床综合征。与其他病因所致的缺血性卒中相比，CES的病因更复杂、病情程度相对更重、预后更差、复发率更高。CES多存在明确的心脏疾病或危险因素，其中由心房颤动（atrial fibrillation，AF）所致者约占70%，近年来对CES（如卒中高危AF）的防治虽有所进步，但仍存在对其认识不足、治疗策略差异大等问题。鉴于以上问题，且国内外尚无全面统一的CES治疗方案（尤其是急性期），故共识制定组以国内外近年来的临床研究为依据，结合我国实际，制订本专家共识，以期更好地规范CES治疗，进而提高CES的临床救治水平。 |
| Purpose of the guideline： | Cardioembolic stroke (CES) is a clinical syndrome in which emboli from the heart and aortic arch pass through the circulation and cause cerebral artery embolism, resulting in corresponding cerebral dysfunction. Compared with ischemic stroke caused by other causes, CES has more complex etiology, more severe condition, worse prognosis and higher recurrence rate. Most CES patients have definite heart diseases or risk factors, of which about 70% are caused by atrial fibrillation (AF). Although there has been progress in the prevention and treatment of CES (such as AF at high risk of stroke) in recent years, there are still some problems such as insufficient understanding and large differences in treatment strategies. In view of the above problems, and there is no comprehensive and unified treatment plan for CES (especially for the acute phase) at home and abroad, the consensus development group formulated this expert consensus based on the clinical research at home and abroad in recent years, combined with the actual situation in China, in order to better standardize the treatment of CES and improve the clinical treatment level of CES. |
